Antitumor effect of novel anti-podoplanin antibody NZ-12 against malignant pleural mesothelioma in an orthotopic xenograft model.

导出 OA

翻译打印收藏纠错

作者： Shinji,Abe ^[1] ; Mika Kato,Kaneko ^[2] ; Yuki,Tsuchihashi ^[3] ; Toshihiro,Izumi ^[4] ; Satoshi,Ogasawara ^[1] ; Naoto,Okada ^[3] ; Chiemi,Sato ^[1] ; Makoto,Tobiume ^[1] ; Kenji,Otsuka ^[2] ; Licht,Miyamoto ^[2] ; Koichiro,Tsuchiya ^[4] ; Kazuyoshi,Kawazoe ^[4] ; Yukinari,Kato ^[1] ; Yasuhiko,Nishioka ^[3]

作者单位： Department of Clinical Pharmacy Practice Pedagogy, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan. ^[1] Department of Respiratory Medicine and Rheumatology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan. ^[2] Department of Regional Innovation, Tohoku University Graduate School of Medicine, Sendai, Japan. ^[3] Department of Medical Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan. ^[4] Department of Respiratory Medicine and Rheumatology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan. yasuhiko@tokushima-u.ac.jp. ^[5]

关键词 NZ-12 antibody-dependent cellular cytotoxicity mesothelioma orthotopic xenograft model podoplanin